NVSEF

Novartis Ag Basel Namen ... (PK) (NVSEF)

Novartis Ag Basel Namen Akt (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:NVSEF

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/11	05 : 30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/06/05	05 : 30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/31	19 : 00	Edgar (US Regulatory)	Form SD - Specialized disclosure report	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/17	05 : 31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/14	05 : 30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/11	05 : 31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/09	05 : 31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/08	05 : 45	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2024/05/07	05 : 30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/06/01	21 : 53	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/05/12	19 : 07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/05/01	05 : 12	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/05/01	05 : 11	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/05/01	05 : 09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/05/01	05 : 07	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/04/28	20 : 59	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/04/02	20 : 51	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/03/27	23 : 16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/03/27	23 : 16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/03/19	19 : 06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/03/03	07 : 28	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/02/28	22 : 30	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/02/15	00 : 03	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/02/13	05 : 35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/02/11	21 : 58	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/01/31	20 : 08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/01/31	00 : 41	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/01/29	23 : 14	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/01/29	23 : 08	Edgar (US Regulatory)	Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
2020/01/29	22 : 54	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)